Revolutions Medical (OTCMKTS:RMCP – Get Free Report) and PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, dividends and institutional ownership.
Risk & Volatility
Revolutions Medical has a beta of -0.43, indicating that its stock price is 143% less volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500.
Insider and Institutional Ownership
89.5% of PROCEPT BioRobotics shares are held by institutional investors. 10.5% of Revolutions Medical shares are held by company insiders. Comparatively, 17.4% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Analyst Recommendations
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Revolutions Medical | 0 | 0 | 0 | 0 | N/A |
PROCEPT BioRobotics | 0 | 0 | 7 | 0 | 3.00 |
PROCEPT BioRobotics has a consensus target price of $78.17, suggesting a potential downside of 1.71%. Given PROCEPT BioRobotics’ higher possible upside, analysts plainly believe PROCEPT BioRobotics is more favorable than Revolutions Medical.
Profitability
This table compares Revolutions Medical and PROCEPT BioRobotics’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Revolutions Medical | N/A | N/A | N/A |
PROCEPT BioRobotics | -58.73% | -37.85% | -26.20% |
Earnings & Valuation
This table compares Revolutions Medical and PROCEPT BioRobotics”s gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Revolutions Medical | N/A | N/A | N/A | N/A | N/A |
PROCEPT BioRobotics | $176.58 million | 23.16 | -$105.90 million | ($2.12) | -37.51 |
Revolutions Medical has higher earnings, but lower revenue than PROCEPT BioRobotics.
Summary
PROCEPT BioRobotics beats Revolutions Medical on 6 of the 9 factors compared between the two stocks.
About Revolutions Medical
Revolutions Medical Corporation, a development stage company, is engaged in the design, development, and commercialization of auto retractable vacuum safety syringes in the United States and internationally. The company develops RevVac auto retractable vacuum safety syringe, which is designed to reduce accidental needle stick injuries and lower the spread of blood borne diseases. It is also developing a suite of magnetic resonance imaging software tools consisting of RevColor, Rev3D, RevDisplay, and RevScan that are designed to enhance general diagnostic confidence through education and research use. The company sells its products to acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons through distributors. Revolutions Medical Corporation was founded in 1996 and is headquartered in Charleston, South Carolina.
About PROCEPT BioRobotics
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Receive News & Ratings for Revolutions Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revolutions Medical and related companies with MarketBeat.com's FREE daily email newsletter.